Wenmin Zhou

682 total citations
15 papers, 488 citations indexed

About

Wenmin Zhou is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Wenmin Zhou has authored 15 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Wenmin Zhou's work include Synthesis and biological activity (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Wenmin Zhou is often cited by papers focused on Synthesis and biological activity (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Wenmin Zhou collaborates with scholars based in China, Hong Kong and United States. Wenmin Zhou's co-authors include Jianye Zhang, Qiaoru Guo, Yuqi Yang, Zhe‐Sheng Chen, Hui Wang, Chang Zou, Yanyan Yan, Jingquan Li, Chongxin Shan and Li Xing and has published in prestigious journals such as Advanced Functional Materials, Chemical Engineering Journal and Drug Discovery Today.

In The Last Decade

Wenmin Zhou

14 papers receiving 479 citations

Peers

Wenmin Zhou
Wenmin Zhou
Citations per year, relative to Wenmin Zhou Wenmin Zhou (= 1×) peers Satoshi Horie

Countries citing papers authored by Wenmin Zhou

Since Specialization
Citations

This map shows the geographic impact of Wenmin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmin Zhou more than expected).

Fields of papers citing papers by Wenmin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenmin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmin Zhou. The network helps show where Wenmin Zhou may publish in the future.

Co-authorship network of co-authors of Wenmin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenmin Zhou. A scholar is included among the top collaborators of Wenmin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenmin Zhou. Wenmin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Guo, Qiaoru, Wenmin Zhou, Guobin Zhang, et al.. (2023). Jaceosidin inhibits the progression and metastasis of NSCLC by regulating miR-34c-3p/Integrin α2β1 axis. Heliyon. 9(5). e16158–e16158. 4 indexed citations
2.
Chen, Qilei, Wenmin Zhou, Yueming Huang, et al.. (2022). Umbelliferone and scopoletin target tyrosine kinases on fibroblast-like synoviocytes to block NF-κB signaling to combat rheumatoid arthritis. Frontiers in Pharmacology. 13. 946210–946210. 7 indexed citations
3.
Yan, Yanyan, Wenmin Zhou, Qiaoru Guo, et al.. (2022). Effect of lathyrol derivatives on non-small cell lung cancer and the possible mechanism.. PubMed. 47(2). 143–152. 2 indexed citations
4.
Huang, Jianwen, Shuai Wang, You Zhou, et al.. (2022). Nanoformulations mediated metastasis brake in cancer therapy via photodynamic-enhanced ferroptosis and regional inflammation management. Chemical Engineering Journal. 451. 138585–138585. 9 indexed citations
5.
Zhou, Wenmin, Qiaoru Guo, Dongyu Huang, et al.. (2022). Brusatol Inhibits Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer PC-9 Cells. World Journal of Traditional Chinese Medicine. 9(4). 454–460. 1 indexed citations
6.
Zhou, Wenmin. (2022). Research on the Control Methods Based on Liquid Level System. Highlights in Science Engineering and Technology. 13. 198–206.
7.
Yan, Yanyan, Qiaoru Guo, Fenghua Wang, et al.. (2021). Cell-Free DNA: Hope and Potential Application in Cancer. Frontiers in Cell and Developmental Biology. 9. 639233–639233. 85 indexed citations
8.
Wu, Wenhao, Wenmin Zhou, Chengxu Wang, et al.. (2021). Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents. Bioorganic & Medicinal Chemistry Letters. 47. 128230–128230. 24 indexed citations
9.
Zhou, Wenmin, Bin Liu, Amin Shavandi, et al.. (2021). Methylation Landscape: Targeting Writer or Eraser to Discover Anti-Cancer Drug. Frontiers in Pharmacology. 12. 690057–690057. 6 indexed citations
10.
Wu, Zhuo‐Xun, Yuqi Yang, Jing‐Quan Wang, et al.. (2021). Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells. Frontiers in Pharmacology. 11. 615824–615824. 24 indexed citations
11.
Xiang, Shengxin, Dongjuan Liu, Wenmin Zhou, et al.. (2021). Liquid‐Metal‐Based Dynamic Thermoregulating and Self‐Powered Electronic Skin. Advanced Functional Materials. 31(26). 121 indexed citations
12.
Su, Chaoyue, Hui Wang, Yunru Liu, et al.. (2020). Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer. Frontiers in Oncology. 10. 554313–554313. 38 indexed citations
13.
Zhou, Wenmin, Hui Wang, Yuqi Yang, et al.. (2020). Chloroquine against malaria, cancers and viral diseases. Drug Discovery Today. 25(11). 2012–2022. 93 indexed citations
14.
Li, Jiajun, Qiaoru Guo, Xueping Lei, et al.. (2020). Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells. Journal of Cancer. 11(21). 6348–6355. 25 indexed citations
15.
Guo, Qiaoru, Lingling Zhang, Jifang Liu, et al.. (2020). Multifunctional microfluidic chip for cancer diagnosis and treatment. Nanotheranostics. 5(1). 73–89. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026